The global market for biostimulants is estimated to be valued at USD 4.97 billion in 2026 and is likely to reach USD 8.77 billion by 2031, growing at a CAGR of 12.0% from 2026 to 2031. The growing demand for organic farming is a significant driver of the biostimulants market, as consumers increasingly seek chemical-free, sustainably produced food. Biostimulants are gaining popularity among farmers looking to enhance crop yield, quality, and resilience to environmental stress without relying on synthetic fertilizers or pesticides. Their ability to improve nutrient uptake, promote soil health, and boost plant growth aligns well with organic farming practices, further accelerating their adoption. Additionally, supportive government policies that encourage sustainable agriculture are contributing to the growing use of biostimulants across various crops.
“The foliar treatment segment holds the highest market share in the biostimulants market by mode of application.”
Foliar treatment holds the highest market share in the biostimulants market due to its effectiveness in delivering nutrients and biostimulant compounds directly to plant leaves, ensuring rapid absorption and a quick response. This method is particularly popular for enhancing plant growth, improving nutrient use efficiency, and boosting stress tolerance in high-value crops like fruits, vegetables, and ornamental plants. Its compatibility with other agrochemicals and ease of application through spraying systems make it a preferred choice among farmers.
“The cereals & grains segment is projected to grow at a significant rate during the forecast period.”
Cereals and grains hold a significant market share in the biostimulants market, driven by the increasing need to enhance crop yield, quality, and resilience against abiotic stress in large-scale farming. As staple crops like wheat, rice, corn, and barley are essential for global food security, farmers are increasingly adopting biostimulants to improve nutrient absorption, root development, and stress tolerance. The ability of biostimulants to boost productivity under adverse environmental conditions, such as drought and salinity, makes them particularly valuable for cereal and grain cultivation. Additionally, the growing demand for sustainable agricultural practices and the need to reduce chemical fertilizer use are further driving the adoption of biostimulants in this segment.
“South America is expected to grow at a significant rate in the biostimulants market.”
South America is expected to grow at a significant rate in the biostimulants market, driven by the region's expanding agricultural sector and increasing adoption of sustainable farming practices. Countries like Brazil and Argentina, major producers of soybeans, corn, and sugarcane, are increasingly using biostimulants to enhance crop yields, quality, and resilience to abiotic stress. Additionally, the region's focus on improving soil health and nutrient efficiency to meet rising global food demand further supports the adoption of biostimulants. Favorable government initiatives promoting organic farming and sustainable agricultural inputs are also contributing to the rapid growth of the biostimulants market in South America.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the biostimulants market:
• By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
• By Designation: Directors– 20%, Managers – 50%, Executives- 30%
• By Region: North America – 25%, Europe – 30%, Asia Pacific – 20%, South America – 15% and Rest of the World –10%
Prominent companies in the market include UPL (India), FMC Corporation (US), Corteva (US), Syngenta Group (Switzerland), Sumitomo Chemical Co., Ltd. (Japan), Nufarm (Australia), Novonesis Group (Denmark), BASF SE (Germany), Bayer AG (Germany), PI Industries (India), T. Stanes and Company Limited (India), Gowan Company (US), J.M. Huber Corporation (US), Haifa Negev technologies LTD (Israel), and Koppert (Netherlands).
Other players include Acadian Plant Health (Canada), Qingdao Seawin Biotech Group Co., Ltd. (China), Sustainable Agro Solutions, S.A.U. (Spain), SEIPASA, S.A. (Spain), OMEX (UK), AlgaEnergy (Spain), LawrieCo (Australia), Aminocore (Germany), Kelpak (South Africa), and Cascadia Seaweed (Canada).
Research Coverage:
This research report categorizes the biostimulants market by active ingredient (humic substances, seaweed extracts, amino acids, minerals & vitamins, microbial amendments), mode of application (foliar, soil, and seed), crop type (cereals & grains, fruits & vegetables, oilseeds & pulses), form (liquid, dry), and region (North America, Europe, Asia Pacific, South America, Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the biostimulants market. A detailed analysis of the key industry players has been conducted to provide insights into their business overviews, services, key strategies, contracts, partnerships, agreements, new service launches, mergers and acquisitions, and recent developments in the biostimulants market. This report covers a competitive analysis of upcoming startups in the biostimulants market ecosystem. Furthermore, industry-specific trends such as technology analysis, ecosystem and market mapping, patent, regulatory landscape, among others, are also covered in the study.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall biostimulants market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (rising need for sustainable agriculture), restraints (commercialization of low-quality biostimulant products), opportunities (technological innovations), and challenges (uncertainty in the global biostimulants regulatory framework) influencing the growth of the biostimulants market.
• New product launch/Innovation: Detailed insights on research & development activities and new product launches in the biostimulants market.
• Market Development: Comprehensive information about lucrative markets – the report analyzes the biostimulants market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the biostimulants market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as UPL (India), FMC Corporation (US), Corteva (US), Syngenta Group (Switzerland), Sumitomo Chemical Co., Ltd. (Japan), and Nufarm (Australia) in the biostimulants market.
圖表清單 List of Tables & Figures
TABLE 1 INCLUSIONS AND EXCLUSIONS 30
TABLE 2 USD EXCHANGE RATES, 2021–2025 32
TABLE 3 INTERCONNECTED MARKETS 55
TABLE 4 KEY MOVES AND STRATEGIC FOCUS 57
TABLE 5 IMPACT OF PORTER’S FIVE FORCES ON BIOSTIMULANT MARKET 59
TABLE 6 ROLE OF COMPANIES IN ECOSYSTEM 67
TABLE 7 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TECHNOLOGY, 2025 (USD/TON) 68
TABLE 8 AVERAGE SELLING PRICE TREND OF BIOFERTILIZER, BY REGION,
2023–2025 (USD/TON) 69
TABLE 9 AVERAGE SELLING PRICE TREND OF BIOSTIMULANTS,
BY ACTIVE INGREDIENT, 2023–2025 (USD/TON) 70
TABLE 10 EXPORT VALUE OF HS CODE 3101, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 71
TABLE 11 IMPORT VALUE OF HS CODE 3101, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 73
TABLE 12 BIOSTIMULANT MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026 73
TABLE 13 US ADJUSTED RECIPROCAL TARIFF RATES 78
TABLE 14 REGIONAL TARIFF IMPACT ON BIOSTIMULANT EXPORTS TO US 79
TABLE 15 KEY PATENTS PERTAINING TO BIOSTIMULANT, 2016–2025 88
TABLE 16 TOP USE CASES AND MARKET POTENTIAL 96
TABLE 17 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES 97
TABLE 18 BIOSTIMULANT MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 98
TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 98
TABLE 20 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 101
TABLE 21 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 102
TABLE 22 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 104
TABLE 23 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 105
TABLE 24 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 106
TABLE 25 GLOBAL INDUSTRY STANDARDS IN BIOSTIMULANT MARKET 108
TABLE 26 KEY INDUSTRY STANDARDS FOR BIOSTIMULANT MARKET 109
TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, FOR FORM 116
TABLE 28 KEY BUYING CRITERIA FOR FORM 117
TABLE 29 BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (USD MILLION) 122
TABLE 30 BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (USD MILLION) 123
TABLE 31 BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 123
TABLE 32 BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 123
TABLE 33 HUMIC BIOSTIMULANTS MARKET, BY REGION, 2021–2025 (USD MILLION) 125
TABLE 34 HUMIC BIOSTIMULANTS MARKET, BY REGION, 2026–2031 (USD MILLION) 125
TABLE 35 HUMIC BIOSTIMULANTS MARKET, BY REGION, 2021–2025 (KT) 125
TABLE 36 HUMIC BIOSTIMULANTS MARKET, BY REGION, 2026–2031 (KT) 126
TABLE 37 HUMIC BIOSTIMULANTS MARKET, BY TYPE, 2021–2025 (USD MILLION) 126
TABLE 38 HUMIC BIOSTIMULANTS MARKET, BY TYPE, 2026–2031 (USD MILLION) 126
TABLE 39 SEAWEED EXTRACT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2021–2025 (USD MILLION) 129
TABLE 40 SEAWEED EXTRACT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 129
TABLE 41 SEAWEED EXTRACT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2021–2025 (KT) 129
TABLE 42 SEAWEED EXTRACT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2026–2031 (KT) 130
TABLE 43 AMINO ACID-BASED BIOSTIMULANTS MARKET,
BY REGION, 2021–2025 (USD MILLION) 131
TABLE 44 AMINO ACID-BASED BIOSTIMULANTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 131
TABLE 45 AMINO ACID-BASED BIOSTIMULANTS MARKET, BY REGION, 2021–2025 (KT) 131
TABLE 46 AMINO ACID-BASED BIOSTIMULANTS MARKET, BY REGION, 2026–2031 (KT) 132
TABLE 47 MICROBIAL AMENDMENTS MARKET, BY REGION, 2021–2025 (USD MILLION) 133
TABLE 48 MICROBIAL AMENDMENTS MARKET, BY REGION, 2026–2031 (USD MILLION) 133
TABLE 49 MICROBIAL AMENDMENTS MARKET, BY REGION, 2021–2025 (KT) 133
TABLE 50 MICROBIAL AMENDMENTS MARKET, BY REGION, 2026–2031 (KT) 134
TABLE 51 MINERAL- & VITAMIN-BASED BIOSTIMULANTS MARKET,
BY REGION, 2021–2025 (USD MILLION) 136
TABLE 52 MINERAL- & VITAMIN-BASED BIOSTIMULANTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 137
TABLE 53 MINERAL- & VITAMIN-BASED BIOSTIMULANTS MARKET,
BY REGION, 2021–2025 (KT) 137
TABLE 54 MINERAL- & VITAMIN-BASED BIOSTIMULANTS MARKET,
BY REGION, 2026–2031 (KT) 137
TABLE 55 OTHER ACTIVE INGREDIENT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2021–2025 (USD MILLION) 138
TABLE 56 OTHER ACTIVE INGREDIENT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2026–2031 (USD MILLION) 138
TABLE 57 OTHER ACTIVE INGREDIENT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2021–2025 (KT) 139
TABLE 58 OTHER ACTIVE INGREDIENT-BASED BIOSTIMULANTS MARKET,
BY REGION, 2026–2031 (KT) 139
TABLE 59 BIOSTIMULANTS MARKET, BY FORM, 2021–2025 (USD MILLION) 142
TABLE 60 BIOSTIMULANTS MARKET, BY FORM, 2026–2031 (USD MILLION) 142
TABLE 61 LIQUID BIOSTIMULANTS MARKET, BY REGION, 2021–2025 (USD MILLION) 143
TABLE 62 LIQUID BIOSTIMULANTS MARKET, BY REGION, 2026–2031 (USD MILLION) 144
TABLE 63 DRY BIOSTIMULANTS MARKET, BY REGION, 2021–2025 (USD MILLION) 145
TABLE 64 DRY BIOSTIMULANTS MARKET, BY REGION, 2026–2031 (USD MILLION) 145
TABLE 65 BIOSTIMULANTS MARKET, BY MODE OF APPLICATION, 2021–2025 (USD MILLION) 148
TABLE 66 BIOSTIMULANTS MARKET, BY MODE OF APPLICATION, 2026–2031 (USD MILLION) 148
TABLE 67 SEED TREATMENT APPLICATION MARKET, BY REGION, 2021–2025 (USD MILLION) 150
TABLE 68 SEED TREATMENT APPLICATION MARKET, BY REGION, 2026–2031 (USD MILLION) 150
TABLE 69 SOIL TREATMENT APPLICATION MARKET, BY REGION, 2021–2025 (USD MILLION) 151
TABLE 70 SOIL TREATMENT APPLICATION MARKET, BY REGION, 2026–2031 (USD MILLION) 152
TABLE 71 FOLIAR TREATMENT APPLICATION MARKET, BY REGION,
2021–2025 (USD MILLION) 153
TABLE 72 FOLIAR TREATMENT APPLICATION MARKET, BY REGION,
2026–2031 (USD MILLION) 153
TABLE 73 BIOSTIMULANTS MARKET, BY CROP TYPE, 2021–2025 (USD MILLION) 156
TABLE 74 BIOSTIMULANTS MARKET, BY CROP TYPE, 2026–2031 (USD MILLION) 156
TABLE 75 BIOSTIMULANTS MARKET IN CEREAL & GRAIN CULTIVATION,
BY REGION, 2021–2025 (USD MILLION) 158
TABLE 76 BIOSTIMULANTS MARKET IN CEREAL & GRAIN CULTIVATION,
BY REGION, 2026–2031 (USD MILLION) 158
TABLE 77 BIOSTIMULANTS MARKET IN CEREAL & GRAIN CULTIVATION,
BY CROP TYPE, 2021–2025 (USD MILLION) 158
TABLE 78 BIOSTIMULANTS MARKET IN CEREAL & GRAIN CULTIVATION,
BY CROP TYPE, 2026–2031 (USD MILLION) 159
TABLE 79 BIOSTIMULANTS MARKET IN OILSEED & PULSE CULTIVATION,
BY REGION, 2021–2025 (USD MILLION) 160
TABLE 80 BIOSTIMULANTS MARKET IN OILSEED & PULSE CULTIVATION,
BY REGION, 2026–2031 (USD MILLION) 160
TABLE 81 BIOSTIMULANTS MARKET IN OILSEED & PULSE CULTIVATION,
BY CROP TYPE, 2021–2025 (USD MILLION) 161
TABLE 82 BIOSTIMULANTS MARKET IN OILSEED & PULSE CULTIVATION,
BY CROP TYPE, 2026–2031 (USD MILLION) 161
TABLE 83 BIOSTIMULANTS MARKET IN FRUIT & VEGETABLE CULTIVATION,
BY REGION, 2021–2025 (USD MILLION) 162
TABLE 84 BIOSTIMULANTS MARKET IN FRUIT & VEGETABLE CULTIVATION,
BY REGION, 2026–2031 (USD MILLION) 163
TABLE 85 BIOSTIMULANTS MARKET IN FRUIT & VEGETABLE CULTIVATION,
BY CROP TYPE, 2021–2025 (USD MILLION) 163
TABLE 86 BIOSTIMULANTS MARKET IN FRUIT & VEGETABLE CULTIVATION,
BY CROP TYPE, 2026–2031 (USD MILLION) 163
TABLE 87 BIOSTIMULANTS MARKET IN FLOWER & ORNAMENTAL CULTIVATION,
BY REGION, 2021–2025 (USD MILLION) 165
TABLE 88 BIOSTIMULANTS MARKET IN FLOWER & ORNAMENTAL CULTIVATION,
BY REGION, 2026–2031 (USD MILLION) 165
TABLE 89 BIOSTIMULANTS MARKET IN OTHER CROP TYPES,
BY REGION, 2021–2025 (USD MILLION) 166
TABLE 90 BIOSTIMULANTS MARKET IN OTHER CROP TYPES,
BY REGION, 2026–2031 (USD MILLION) 166
TABLE 91 BIOSTIMULANTS MARKET, BY REGION, 2021–2025 (USD MILLION) 169
TABLE 92 BIOSTIMULANTS MARKET, BY REGION, 2026–2031 (USD MILLION) 169
TABLE 93 BIOSTIMULANTS MARKET, BY REGION, 2021–2025 (KT) 170
TABLE 94 BIOSTIMULANTS MARKET, BY REGION, 2026–2031 (KT) 170
TABLE 95 NORTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY,
2021–2025 (USD MILLION) 171
TABLE 96 NORTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 171
TABLE 97 NORTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY, 2021–2025 (KT) 172
TABLE 98 NORTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY, 2026–2031 (KT) 172
TABLE 99 NORTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 172
TABLE 100 NORTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 173
TABLE 101 NORTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (KT) 173
TABLE 102 NORTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (KT) 173
TABLE 103 NORTH AMERICA: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2021–2025 (USD MILLION) 174
TABLE 104 NORTH AMERICA: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2026–2031 (USD MILLION) 174
TABLE 105 NORTH AMERICA: BIOSTIMULANTS MARKET, BY CROP TYPE,
2021–2025 (USD MILLION) 174
TABLE 106 NORTH AMERICA: BIOSTIMULANTS MARKET, BY CROP TYPE,
2026–2031 (USD MILLION) 175
TABLE 107 NORTH AMERICA: BIOSTIMULANTS MARKET, BY FORM,
2021–2025 (USD MILLION) 175
TABLE 108 NORTH AMERICA: BIOSTIMULANTS MARKET, BY FORM,
2026–2031 (USD MILLION) 175
TABLE 109 US: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 176
TABLE 110 US: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 177
TABLE 111 US: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 177
TABLE 112 US: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 177
TABLE 113 CANADA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 179
TABLE 114 CANADA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 179
TABLE 115 CANADA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 179
TABLE 116 CANADA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 180
TABLE 117 MEXICO: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 181
TABLE 118 MEXICO: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 181
TABLE 119 MEXICO: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 182
TABLE 120 MEXICO: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 182
TABLE 121 EUROPE: BIOSTIMULANTS MARKET, BY COUNTRY, 2021–2025 (USD MILLION) 183
TABLE 122 EUROPE: BIOSTIMULANTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 183
TABLE 123 EUROPE: BIOSTIMULANTS MARKET, BY COUNTRY, 2021–2025 (KT) 184
TABLE 124 EUROPE: BIOSTIMULANTS MARKET, BY COUNTRY, 2026–2031 (KT) 184
TABLE 125 EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 184
TABLE 126 EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 185
TABLE 127 EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 185
TABLE 128 EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 185
TABLE 129 EUROPE: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2021–2025 (USD MILLION) 186
TABLE 130 EUROPE: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2026–2031 (USD MILLION) 186
TABLE 131 EUROPE: BIOSTIMULANTS MARKET, BY CROP TYPE, 2021–2025 (USD MILLION) 186
TABLE 132 EUROPE: BIOSTIMULANTS MARKET, BY CROP TYPE, 2026–2031 (USD MILLION) 187
TABLE 133 EUROPE: BIOSTIMULANTS MARKET, BY FORM, 2021–2025 (USD MILLION) 187
TABLE 134 EUROPE: BIOSTIMULANTS MARKET, BY FORM 2026–2031 (USD MILLION) 187
TABLE 135 SPAIN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 188
TABLE 136 SPAIN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 189
TABLE 137 SPAIN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 189
TABLE 138 SPAIN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 189
TABLE 139 ITALY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 191
TABLE 140 ITALY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 191
TABLE 141 ITALY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 191
TABLE 142 ITALY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 192
TABLE 143 FRANCE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 193
TABLE 144 FRANCE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 193
TABLE 145 FRANCE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 193
TABLE 146 FRANCE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 194
TABLE 147 GERMANY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 195
TABLE 148 GERMANY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 195
TABLE 149 GERMANY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 196
TABLE 150 GERMANY: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 196
TABLE 151 UK: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 197
TABLE 152 UK: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 198
TABLE 153 UK: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 198
TABLE 154 UK: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 198
TABLE 155 REST OF EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 199
TABLE 156 REST OF EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 200
TABLE 157 REST OF EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (KT) 200
TABLE 158 REST OF EUROPE: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (KT) 200
TABLE 159 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY COUNTRY, 2021–2025 (USD MILLION) 202
TABLE 160 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 203
TABLE 161 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY COUNTRY, 2021–2025 (KT) 203
TABLE 162 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY COUNTRY, 2026–2031 (KT) 203
TABLE 163 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 204
TABLE 164 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 204
TABLE 165 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 204
TABLE 166 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 205
TABLE 167 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2021–2025 (USD MILLION) 205
TABLE 168 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2026–2031 (USD MILLION) 205
TABLE 169 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY CROP TYPE,
2021–2025 (USD MILLION) 206
TABLE 170 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY CROP TYPE,
2026–2031 (USD MILLION) 206
TABLE 171 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY FORM, 2021–2025 (USD MILLION) 206
TABLE 172 ASIA PACIFIC: BIOSTIMULANTS MARKET, BY FORM, 2026–2031 (USD MILLION) 206
TABLE 173 CHINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 208
TABLE 174 CHINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 208
TABLE 175 CHINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 208
TABLE 176 CHINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 209
TABLE 177 JAPAN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 210
TABLE 178 JAPAN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 210
TABLE 179 JAPAN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 211
TABLE 180 JAPAN: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 211
TABLE 181 INDIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 212
TABLE 182 INDIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 213
TABLE 183 INDIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 213
TABLE 184 INDIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 213
TABLE 185 AUSTRALIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 215
TABLE 186 AUSTRALIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 215
TABLE 187 AUSTRALIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 215
TABLE 188 AUSTRALIA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 216
TABLE 189 REST OF ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 217
TABLE 190 REST OF ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 217
TABLE 191 REST OF ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (KT) 217
TABLE 192 REST OF ASIA PACIFIC: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (KT) 218
TABLE 193 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY,
2021–2025 (USD MILLION) 219
TABLE 194 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY,
2026–2031 (USD MILLION) 219
TABLE 195 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY, 2021–2025 (KT) 219
TABLE 196 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY COUNTRY, 2026–2031 (KT) 220
TABLE 197 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 220
TABLE 198 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 220
TABLE 199 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (KT) 221
TABLE 200 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (KT) 221
TABLE 201 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2021–2025 (USD MILLION) 221
TABLE 202 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2026–2031 (USD MILLION) 222
TABLE 203 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY CROP TYPE,
2021–2025 (USD MILLION) 222
TABLE 204 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY CROP TYPE,
2026–2031 (USD MILLION) 222
TABLE 205 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY FORM,
2021–2025 (USD MILLION) 223
TABLE 206 SOUTH AMERICA: BIOSTIMULANTS MARKET, BY FORM 2026–2031 (USD MILLION) 223
TABLE 207 BRAZIL: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 224
TABLE 208 BRAZIL: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 224
TABLE 209 BRAZIL: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 225
TABLE 210 BRAZIL: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 225
TABLE 211 ARGENTINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 226
TABLE 212 ARGENTINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 227
TABLE 213 ARGENTINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 227
TABLE 214 ARGENTINA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 227
TABLE 215 REST OF SOUTH AMERICA: BIOSTIMULANTS MARKET,
BY ACTIVE INGREDIENT, 2021–2025 (USD MILLION) 229
TABLE 216 REST OF SOUTH AMERICA: BIOSTIMULANTS MARKET,
BY ACTIVE INGREDIENT, 2026–2031 (USD MILLION) 229
TABLE 217 REST OF SOUTH AMERICA: BIOSTIMULANTS MARKET,
BY ACTIVE INGREDIENT, 2021–2025 (KT) 229
TABLE 218 REST OF SOUTH AMERICA: BIOSTIMULANTS MARKET,
BY ACTIVE INGREDIENT, 2026–2031 (KT) 230
TABLE 219 ROW: BIOSTIMULANTS MARKET, BY SUBREGION, 2021–2025 (USD MILLION) 231
TABLE 220 ROW: BIOSTIMULANTS MARKET, BY SUBREGION, 2026–2031 (USD MILLION) 231
TABLE 221 ROW: BIOSTIMULANTS MARKET, BY SUBREGION, 2021–2025 (KT) 231
TABLE 222 ROW: BIOSTIMULANTS MARKET, BY SUBREGION, 2026–2031 (KT) 231
TABLE 223 ROW: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 232
TABLE 224 ROW: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 232
TABLE 225 ROW: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 232
TABLE 226 ROW: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 233
TABLE 227 ROW: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2021–2025 (USD MILLION) 233
TABLE 228 ROW: BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2026–2031 (USD MILLION) 233
TABLE 229 ROW: BIOSTIMULANTS MARKET, BY CROP TYPE, 2021–2025 (USD MILLION) 233
TABLE 230 ROW: BIOSTIMULANTS MARKET, BY CROP TYPE, 2026–2031 (USD MILLION) 234
TABLE 231 ROW: BIOSTIMULANTS MARKET, BY FORM, 2021–2025 (USD MILLION) 234
TABLE 232 ROW: BIOSTIMULANTS MARKET, BY FORM, 2026–2031 (USD MILLION) 234
TABLE 233 AFRICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 235
TABLE 234 AFRICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 236
TABLE 235 AFRICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2021–2025 (KT) 236
TABLE 236 AFRICA: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026–2031 (KT) 236
TABLE 237 MIDDLE EAST: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (USD MILLION) 238
TABLE 238 MIDDLE EAST: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (USD MILLION) 238
TABLE 239 MIDDLE EAST: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2021–2025 (KT) 238
TABLE 240 MIDDLE EAST: BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT,
2026–2031 (KT) 239
TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BIOSTIMULANTS MARKET, 2020–2026 241
TABLE 242 BIOSTIMULANTS MARKET: DEGREE OF COMPETITION, 2025 244
TABLE 243 BIOSTIMULANTS MARKET: REGION FOOTPRINT, 2025 248
TABLE 244 BIOSTIMULANTS MARKET: ACTIVE INGREDIENT FOOTPRINT, 2025 249
TABLE 245 BIOSTIMULANTS MARKET: MODE OF APPLICATION FOOTPRINT, 2025 250
TABLE 246 BIOSTIMULANTS MARKET: FORMULATION FOOTPRINT, 2025 251
TABLE 247 BIOSTIMULANTS MARKET: LIST OF KEY STARTUPS/SMES 253
TABLE 248 BIOSTIMULANTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025 254
TABLE 249 BIOSTIMULANTS MARKET: PRODUCT/SERVICE LAUNCHES,
JANUARY 2021–JUNE 2026 257
TABLE 250 BIOSTIMULANTS MARKET: DEALS, JANUARY 2021–JUNE 2026 258
TABLE 251 BIOSTIMULANTS MARKET: EXPANSIONS, JANUARY 2021–JUNE 2026 259
TABLE 252 UPL: COMPANY OVERVIEW 261
TABLE 253 UPL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 262
TABLE 254 UPL: PRODUCT LAUNCHES 265
TABLE 255 UPL: DEALS 266
TABLE 256 FMC CORPORATION: COMPANY OVERVIEW 268
TABLE 257 FMC CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 269
TABLE 258 FMC CORPORATION: PRODUCT LAUNCHES 271
TABLE 259 FMC CORPORATION: DEALS 271
TABLE 260 FMC CORPORATION: EXPANSIONS 272
TABLE 261 FMC CORPORATION: OTHER DEVELOPMENTS 272
TABLE 262 CORTEVA: BUSINESS OVERVIEW 274
TABLE 263 CORTEVA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
TABLE 264 CORTEVA: PRODUCT LAUNCHES 277
TABLE 265 CORTEVA AGRISCIENCE: DEALS 278
TABLE 266 SYNGENTA GROUP: BUSINESS OVERVIEW 280
TABLE 267 SYNGENTA GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
TABLE 268 SYNGENTA GROUP: PRODUCT LAUNCHES 283
TABLE 269 SYNGENTA GROUP: DEALS 284
TABLE 270 SYNGENTA CROP: EXPANSIONS 286
TABLE 271 SUMITOMO CHEMICAL CO., LTD.: COMPANY OVERVIEW 288
TABLE 272 SUMITOMO CHEMICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 289
TABLE 273 SUMITOMO CHEMICAL CO., LTD: DEALS 291
TABLE 274 SUMITOMO CHEMICAL CO., LTD: EXPANSIONS 292
TABLE 275 NUFARM: COMPANY OVERVIEW 294
TABLE 276 NUFARM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 295
TABLE 277 NUFARM: PRODUCT LAUNCHES 297
TABLE 278 NUFARM: OTHER DEVELOPMENTS 298
TABLE 279 NOVONESIS GROUP: COMPANY OVERVIEW 299
TABLE 280 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 301
TABLE 281 NOVONESIS: PRODUCT LAUNCHES 302
TABLE 282 NOVONESIS GROUP: DEALS 303
TABLE 283 BASF SE: COMPANY OVERVIEW 304
TABLE 284 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 305
TABLE 285 BASF SE: DEALS 306
TABLE 286 BASF SE: EXPANSIONS 307
TABLE 287 BAYER AG: COMPANY OVERVIEW 308
TABLE 288 BAYER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 309
TABLE 289 BAYER AG: DEALS 310
TABLE 290 PI INDUSTRIES: COMPANY OVERVIEW 311
TABLE 291 PI INDUSTRIES: PRODUCTS/SOLUTIONS/SERVICES OFFERED 312
TABLE 292 PI INDUSTRIES: DEALS 313
TABLE 293 T.STANES AND COMPANY LIMITED: COMPANY OVERVIEW 314
TABLE 294 T.STANES AND COMPANY LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 315
TABLE 295 J.M. HUBER CORPORATION: COMPANY OVERVIEW 316
TABLE 296 J.M. HUBER CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 316
TABLE 297 J.M. HUBER CORPORATION: DEALS 318
TABLE 298 HAIFA NEGEV TECHNOLOGIES LTD: COMPANY OVERVIEW 319
TABLE 299 HAIFA NEGEV TECHNOLOGIES LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 319
TABLE 300 HAIFA NEGEV TECHNOLOGIES LTD: PRODUCT LAUNCHES 320
TABLE 301 HAIFA NEGEV TECHNOLOGIES LTD: DEALS 321
TABLE 302 HAIFA NEGEV TECHNOLOGIES LTD: EXPANSIONS 321
TABLE 303 GOWAN COMPANY: COMPANY OVERVIEW 323
TABLE 304 GOWAN COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 323
TABLE 305 GOWAN COMPANY: DEALS 324
TABLE 306 KOPPERT: COMPANY OVERVIEW 325
TABLE 307 KOPPERT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 325
TABLE 308 KOPPERT: DEALS 326
TABLE 309 KOPPERT: EXPANSIONS 327
TABLE 310 ACADIAN SEAPLANTS LIMITED: BUSINESS OVERVIEW 328
TABLE 311 ACADIAN SEAPLANTS LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 328
TABLE 312 ACADIAN SEAPLANTS LIMITED: DEALS 329
TABLE 313 QINGDAO SEAWIN BIOTECH GROUP CO., LTD.: BUSINESS OVERVIEW 330
TABLE 314 QINGDAO SEAWIN BIOTECH GROUP CO., LTD.: PRODUCTS/SOLUTIONS/
SERVICES OFFERED 330
TABLE 315 OMEX: BUSINESS OVERVIEW 332
TABLE 316 OMEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED 332
TABLE 317 SEIPASA, S.A.: COMPANY OVERVIEW 334
TABLE 318 SEIPASA, S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 334
TABLE 319 SEIPASA, S.A.: PRODUCT LAUNCHES 335
TABLE 320 SEIPASA, S.A.: EXPANSIONS 336
TABLE 321 SUSTAINABLE AGRO SOLUTIONS, S.A.U.: COMPANY OVERVIEW 338
TABLE 322 SUSTAINABLE AGRO SOLUTIONS, S.A.U.: PRODUCTS/SOLUTIONS/
SERVICES OFFERED 338
TABLE 323 SUSTAINABLE AGRO SOLUTIONS, S.A.U.: DEALS 339
TABLE 324 ALGAENERGY: COMPANY OVERVIEW 340
TABLE 325 LAWRIECO: COMPANY OVERVIEW 341
TABLE 326 AMINOCORE: COMPANY OVERVIEW 342
TABLE 327 KELPAK: COMPANY OVERVIEW 343
TABLE 328 CASCADIA SEAWEED: COMPANY OVERVIEW 343
TABLE 329 LIST OF SECONDARY SOURCES 345
TABLE 330 ADJACENT MARKET 355
TABLE 331 BIOPESTICIDES MARKET, BY TYPE, 2019–2023 (USD MILLION) 356
TABLE 332 BIOPESTICIDES MARKET, BY TYPE, 2024–2029 (USD MILLION) 356
TABLE 333 BIOPESTICIDES MARKET, BY TYPE, 2019–2023 (KT) 356
TABLE 334 BIOPESTICIDES MARKET, BY TYPE, 2024–2029 (KT) 357
TABLE 335 PLANT GROWTH REGULATORS MARKET, BY TYPE, 2019–2023 (USD MILLION) 358
TABLE 336 PLANT GROWTH REGULATORS MARKET, BY TYPE, 2024–2029 (USD MILLION) 358
FIGURE 1 MARKET SEGMENTATION 30
FIGURE 2 STUDY YEARS CONSIDERED 31
FIGURE 3 KEY INSIGHTS AND MARKET HIGHLIGHTS 34
FIGURE 4 BIOSTIMULANTS MARKET, BY TYPE, 2026–2031 (USD MILLION) 34
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BIOSTIMULANTS
MARKET, 2021–2025 35
FIGURE 6 DISRUPTIVE TRENDS IMPACTING GROWTH OF BIOSTIMULANTS MARKET 36
FIGURE 7 HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN BIOSTIMULANTS MARKET, 2026 37
FIGURE 8 EUROPE TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 38
FIGURE 9 GROWING DEMAND FOR SUSTAINABLE FARMING METHOD
IN BIOSTIMULANTS MARKET 39
FIGURE 10 FRUITS & VEGETABLES AND ASIA PACIFIC ACCOUNTED FOR LARGEST MARKET SHARES IN 2026 40
FIGURE 11 LIQUID SEGMENT TO LEAD MARKET IN 2026 40
FIGURE 12 FOLIAR TREATMENT SEGMENT TO LEAD MARKET IN 2026 41
FIGURE 13 SEAWEED EXTRACT SEGMENT TO LEAD MARKET IN 2026 41
FIGURE 14 INDIA TO REGISTER HIGHEST CAGR DURING 2026–2031 42
FIGURE 15 MARKET DYNAMICS: BIOSTIMULANTS MARKET 44
FIGURE 16 WORLD DISTRIBUTION OF ORGANIC PRODUCERS, BY REGION, 2023 45
FIGURE 17 GLOBAL EXPORT VALUE OF FRUITS AND VEGETABLES,
BY COMMODITY, 2000–2020 (USD BILLION) 47
FIGURE 18 BIOSTIMULANT MARKET: PORTER’S FIVE FORCES ANALYSIS 58
FIGURE 19 GROWTH IN GLOBAL AGRICULTURAL VALUE-ADDED SUPPORTS DEMAND FOR BIOSTIMULANTS (2015-2024) 61
FIGURE 20 GLOBAL FERTILIZER CONSUMPTION, 2014–2023 62
FIGURE 21 BIOSTIMULANT MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 22 KEY PARTICIPANTS IN BIOSTIMULANTS ECOSYSTEM 66
FIGURE 23 BIOSTIMULANT MARKET: ECOSYSTEM ANALYSIS 66
FIGURE 24 AVERAGE SELLING PRICE TREND OF BIOSTIMULANT,
BY REGION, 2023–2025 (USD/TON) 68
FIGURE 25 AVERAGE SELLING PRICE TREND OF BIOSTIMULANTS,
BY ACTIVE INGREDIENT, 2023–2025 (USD/TON) 69
FIGURE 26 EXPORT VALUE OF HS CODE 3101, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 71
FIGURE 27 IMPORT VALUE OF HS CODE 3101, BY KEY COUNTRY,
2021–2025 (USD THOUSAND) 72
FIGURE 28 INVESTMENT & FUNDING SCENARIO OF FEW MAJOR PLAYERS, 2010–2026 74
FIGURE 29 BIOSTIMULANT MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMER BUSINESS 75
FIGURE 30 NUMBER OF PATENTS APPLIED FOR AND GRANTED, 2016–2026 87
FIGURE 31 FUTURE APPLICATIONS 93
FIGURE 32 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 100
FIGURE 33 BIOSTIMULANT MARKET: DECISION-MAKING FACTORS 114
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY FORM 115
FIGURE 35 KEY INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR FORM 116
FIGURE 36 BIOSTIMULANTS MARKET, BY ACTIVE INGREDIENT, 2026 VS. 2031 (USD MILLION) 122
FIGURE 37 BIOSTIMULANTS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 142
FIGURE 38 BIOSTIMULANTS MARKET, BY MODE OF APPLICATION,
2026 VS. 2031 (USD MILLION) 148
FIGURE 39 BIOSTIMULANTS MARKET, BY CROP TYPE, 2025 VS. 2030 (USD MILLION) 156
FIGURE 40 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 169
FIGURE 41 ASIA PACIFIC: REGIONAL SNAPSHOT 202
FIGURE 42 ANNUAL REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD BILLION) 242
FIGURE 43 BIOSTIMULANTS MARKET: MARKET SHARE ANALYSIS, 2025 243
FIGURE 44 BIOSTIMULANTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 246
FIGURE 45 COMPANY FOOTPRINT, 2025 247
FIGURE 46 BIOSTIMULANTS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 252
FIGURE 47 COMPANY VALUATION OF FEW MAJOR PLAYERS, 2025 255
FIGURE 48 EV/EBITDA OF KEY COMPANIES, 2025 255
FIGURE 49 BRAND/PRODUCT/SERVICE ANALYSIS, BY KEY PLAYERS OF BIOSTIMULANTS 256
FIGURE 50 UPL: COMPANY SNAPSHOT 262
FIGURE 51 FMC CORPORATION: COMPANY SNAPSHOT 269
FIGURE 52 CORTEVA: COMPANY SNAPSHOT 275
FIGURE 53 SYNGENTA GROUP: COMPANY SNAPSHOT 281
FIGURE 54 SUMITOMO CHEMICAL CO., LTD.: COMPANY SNAPSHOT 289
FIGURE 55 NUFARM: COMPANY SNAPSHOT 295
FIGURE 56 NOVONESIS GROUP: COMPANY SNAPSHOT 300
FIGURE 57 BASF SE: COMPANY SNAPSHOT 305
FIGURE 58 BAYER AG: COMPANY SNAPSHOT 309
FIGURE 59 PI INDUSTRIES: COMPANY SNAPSHOT 312
FIGURE 60 T.STANES AND COMPANY LIMITED: COMPANY SNAPSHOT 314
FIGURE 61 BIOSTIMULANTS MARKET: RESEARCH DESIGN 344
FIGURE 62 KEY DATA FROM SECONDARY SOURCES 346
FIGURE 63 KEY DATA FROM PRIMARY SOURCES 347
FIGURE 64 INSIGHTS FROM INDUSTRY EXPERTS 347
FIGURE 65 BREAKDOWN OF PRIMARIES, BY COMPANY TYPE, DESIGNATION, AND REGION 348
FIGURE 66 BIOSTIMULANTS MARKET: BOTTOM-UP CALCULATION 349
FIGURE 67 BIOSTIMULANTS MARKET: DEMAND-SIDE CALCULATION 350
FIGURE 68 BIOSTIMULANTS MARKET: TOP-DOWN APPROACH 351
FIGURE 69 BIOSTIMULANTS MARKET SIZE ESTIMATION STEPS AND RESPECTIVE
SOURCES: SUPPLY SIDE 352
FIGURE 70 BIOSTIMULANTS MARKET: SUPPLY-SIDE ANALYSIS 352
FIGURE 71 DATA TRIANGULATION METHODOLOGY 353
FIGURE 72 RESEARCH ASSUMPTIONS 354
FIGURE 73 RESEARCH LIMITATIONS AND RISK ASSESSMENT 354